Home » Topics » Medical technology

Medical technology
RSS

Other News To Note

Dec. 4, 2007

Targacept's TC-2696 Fails Trial; Other NNR Programs Advance

Dec. 4, 2007

By Trista Morrison

Teva Amends Andromeda Deal For Phase III Diabetes Drug

Dec. 4, 2007

Addex Inks $170M Merck Deal For CNS Drug Development

Dec. 4, 2007

By Cormac Sheridan

NIH Panel Won't Rule Out Gene Therapy in Trial Death

Dec. 4, 2007

Study Says Oncogene C-Myc Has Surprise Role In Velcade Success

Dec. 4, 2007

By Anette Breindl

Another Dose Of ESA News: Aranesp Early Data Negative

Dec. 4, 2007

Today s MDD food for med-tech thought

Dec. 4, 2007

StemCells exploring possible buy of Progenitor Cell Therapy

Dec. 4, 2007

Ortho giants Stryker, Zimmer see strength in their markets

Dec. 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...